|
Q4 2020
Filed on Feb 11, 2021
|
10,126
|
$17.99 - $24.63
$182K - $249K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,400
|
$7.82 - $9.02
$81.3K - $93.8K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,105
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,400
|
$2.28 - $6.84
$42K - $126K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
15,270
|
$55.93 - $82.78
$854K - $1.26M
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
46,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
16,013
|
$1.99 - $3.25
$31.9K - $52K
|
|
Oaktree Strategic Income Cor
|
Q4 2020
Filed on Feb 11, 2021
|
10,350
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
11,206
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
147,521
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
37,836
|
$25.02 - $30.05
$947K - $1.14M
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,484
|
$39.2 - $45.68
$725K - $844K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
20,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
21,525
|
$3.38 - $4.3
$72.8K - $92.6K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
40,196
|
$0.63 - $1.51
$25.3K - $60.7K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
20,429
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
13,306
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
5,619
|
$46.13 - $57.62
$259K - $324K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
27,105
|
$5.93 - $11.46
$161K - $311K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
26,233
|
N/A
|
|
Proteostasis Therapeutics In
|
Q4 2020
Filed on Feb 11, 2021
|
19,847
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
16,417
|
$6.43 - $10.5
$106K - $172K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,850
|
$1.5 - $2.02
$16.3K - $21.9K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,177
|
$32.82 - $34.97
$400K - $426K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,000
|
$0.2 - $0.4
$3.6K - $7.2K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
22,592
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
13,750
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
4,099
|
$51.38 - $52.31
$211K - $214K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
9,785
|
$20.37 - $25.01
$199K - $245K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
17,861
|
$17.06 - $22.15
$305K - $396K
|
|
Fortress Value Acquisition C
|
Q4 2020
Filed on Feb 11, 2021
|
42,907
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
17,905
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
13,650
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
1,667
|
N/A
|
|
Perth Mint Physical Gold ETF
|
Q4 2020
Filed on Feb 11, 2021
|
12,360
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
25,125
|
$12.12 - $28.26
$305K - $710K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,400
|
$2.7 - $7.2
$28.1K - $74.9K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
5,507
|
$46.09 - $54.74
$254K - $301K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
4,309
|
$52.41 - $73.52
$226K - $317K
|
|
Social Cap Hdosphia Hldg CO
|
Q4 2020
Filed on Feb 11, 2021
|
12,610
|
N/A
|
|
Tortoise Acquisition Corp
|
Q4 2020
Filed on Feb 11, 2021
|
6,115
|
N/A
|
|
Zomedica Pharmaceuticals Cor
|
Q4 2020
Filed on Feb 11, 2021
|
228,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 05, 2020
|
229
|
$1699.07 - $1928.0
$389K - $442K
|
|
|
Q3 2020
Filed on Nov 05, 2020
|
39,643
|
N/A
|
|
Center Coast Brkfld Mlp Enrg
|
Q3 2020
Filed on Nov 05, 2020
|
12,662
|
N/A
|
|
Clearbridge Mlp And Midstrm
|
Q3 2020
Filed on Nov 05, 2020
|
18,391
|
N/A
|
|
Clearbridge Mlp And Midstrm
|
Q3 2020
Filed on Nov 05, 2020
|
11,339
|
N/A
|
|
|
Q3 2020
Filed on Nov 05, 2020
|
128,128
|
N/A
|
|
Fiduciary Claymore Engry Inf
|
Q3 2020
Filed on Nov 05, 2020
|
13,590
|
N/A
|
|
First Tr Exch Trd Alphdx Fd
|
Q3 2020
Filed on Nov 05, 2020
|
9,708
|
N/A
|
|